Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics -> Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Checklist Plug-and-play starting point Audits & Inspection

Checklist: One-Day FDA Inspectional Assessment Readiness

A plug-and-play readiness checklist for FDA's one-day inspectional assessment pilot: pre-staged artifacts across all six systems, a standing-ready front room team, and the go/no-go confirmations a site needs before the investigator walks in with no multi-day runway, with a filled specimen.

Document type: Checklist

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use readiness checklist for FDA’s one-day inspectional assessment pilot. Replace every <<FILL: ...>> placeholder with your specifics and route it through your normal document control. A filled specimen follows. Confirm the pilot’s current scope and status against FDA’s own announcements before relying on this as written, since a pilot program’s criteria can change.

Document control header

FieldEntry
Document titleOne-Day FDA Inspectional Assessment Readiness Checklist
Document number<<FILL: CHK-ID, e.g. QA-CHK-073>>
Version<<FILL: version>>
Effective date<<FILL: effective date>>
Site<<FILL: facility name>>
Completed by<<FILL: name, role>>

1. Why this checklist is different from a standard PAI or system-level readiness check

A one-day assessment compresses the same scrutiny a multi-day inspection applies into a single visit, with no overnight runway to assemble a record the team did not already have staged. The gap this checklist closes is not depth of control, it is speed of production: everything below has to be retrievable within the visit, not within a day or two after it.

2. Standing readiness: confirm before any notice is possible

Because facilities are selected on risk-based criteria without the lead time a PAI often carries, treat every item below as always-on, not something assembled after notice.

#ItemStatusEvidence locationAction ref
1A named front room team (coordinator, at least one scribe, SME contact list by system) is current and can convene within <<FILL: e.g. 1 hour>> of notice<<FILL>><<FILL>><<FILL>>
2Validation state summaries for all GxP systems are current and centrally indexed, not scattered across owners<<FILL>><<FILL>><<FILL>>
3Access lists with role justification are current for every validated system<<FILL>><<FILL>><<FILL>>
4The last periodic audit trail review for each high-criticality system is complete and signed<<FILL>><<FILL>><<FILL>>
5Open deviations and OOS records are current in status, with no aged-but-silent backlog<<FILL>><<FILL>><<FILL>>
6Training records for staff likely to be interviewed are current, with no lapsed qualifications<<FILL>><<FILL>><<FILL>>
7A document request log template and two-copy document control practice are ready to deploy immediately, not set up after the investigator arrives<<FILL>><<FILL>><<FILL>>

3. Coverage across the six-system model

Because a one-day visit may sample any of the six systems with no indication in advance of which one, confirm baseline readiness across all of them, not only the system most recently inspected.

SystemLast internal self-check dateAny known open gapAction ref
Quality system<<FILL>><<FILL>><<FILL>>
Facilities and equipment<<FILL>><<FILL>><<FILL>>
Materials<<FILL>><<FILL>><<FILL>>
Production<<FILL>><<FILL>><<FILL>>
Packaging and labeling<<FILL>><<FILL>><<FILL>>
Laboratory controls<<FILL>><<FILL>><<FILL>>

4. The day itself: go/no-go confirmations within the first hour

#ItemConfirmed
1Investigator credentials and Form FDA 482 reviewed and logged, scope confirmed verbatim<<FILL: Y/N>>
2Front room and back room roles activated per the standing list in Section 2<<FILL: Y/N>>
3Leadership notified and available for the daily huddle expectation, compressed to same-day given the single-day format<<FILL: Y/N>>
4Document request log opened and in use from the first request<<FILL: Y/N>>
5Scribe assigned and present for every interaction from the opening meeting onward<<FILL: Y/N>>

5. Acceptance criteria

  • Every item in Section 2 is confirmed current as a standing state, not assembled in response to this checklist.
  • No system in Section 3 shows an open gap without a logged action reference and owner.
  • The Section 4 confirmations can all be completed within the stated time of the opening meeting, demonstrating the team can mobilize without a multi-day runway.

6. Escalation

If any Section 2 item is not current when this checklist is run as a standing self-audit (not during a live assessment), escalate to the inspection readiness lead and site quality head immediately and open a tracked action; do not wait for the next scheduled review cycle, since a one-day assessment can arrive with materially less notice than a routine surveillance inspection.


Filled specimen

A drug product manufacturing site runs this checklist as a quarterly standing self-audit, not in response to any notice.

#ItemStatusEvidence locationAction ref
1Front room team current, can convene within 1 hourConfirmed, roster last updated 3 weeks agoInspection readiness SharePoint, roster tabN/A
4Audit trail reviews for high-criticality systems current and signedConfirmed for 7 of 8 systems; HPLC-11 review 4 days overdueQMS periodic review trackerCAPA-2026-0511 opened same day
5Deviations and OOS current, no silent backlogOne deviation open 38 days against a 30-day target, justified extension on file and approvedDeviation logNo action beyond the approved extension

Six-system coverage: all six systems show a self-check within the last quarter; packaging and labeling flagged a minor gap (a label reconciliation SOP revision pending final approval), tracked under CC-2026-0298, not yet a live finding.

The quarterly run surfaced one genuinely overdue item (the HPLC-11 audit trail review) before any inspection notice, which is exactly the point: the gap was found and a CAPA opened from the site’s own standing check, not from an investigator’s question.

Common inspection findings this checklist prevents

  • A site treats “readiness” as something built after notice of an inspection, which a one-day assessment’s compressed timeline does not allow time for.
  • A validated system’s audit trail review lapses quietly because no standing, dated self-check surfaces it before an investigator asks.
  • The front room team is identified on paper but has never actually convened, so the one-day assessment’s opening hour is lost to logistics rather than substance.

How to adapt this checklist

  1. Run this as a recurring standing self-audit (for example quarterly), not only after a facility learns it may be a pilot candidate; the pilot’s selection criteria do not guarantee advance notice.
  2. Tailor Section 3’s system list if your site’s compliance program model differs from the six-system structure.
  3. Confirm the pilot’s current scope, selection criteria, and status directly against FDA’s own published materials before treating any detail here as settled, since a pilot program can be modified or discontinued.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.